Obesity is an increasing health problem worldwide. Visceral fat has been associated with a higher risk of metabolic syndrome. The co-occurrence of a cluster of factors is constantly increasing, making this syndrome the leading cause of cardiovascular diseases and diabetes type 2. The present investigation showed that visceral fat in overweight and obese subjects with metabolic syndrome has a high correlation with HOMA, triacylglycerol, increased wait hip ratio and several other metabolic variables. The only parameter that did not differ among the three groups of subjects was the level of cholesterol
Metabolic syndrome (MetS) represents a combination of cardiometabolic risk factors, including viscer...
There is currently substantial confusion between the conceptual definition of the metabolic syndrome...
Metabolic syndrome has been the topic of countless publications. It still remains a subject of debat...
In this review, we have analyzed the role of visceral obesity in the occurrence of metabolic syndrom...
In this review, we have analyzed the role of visceral obesity in the occurrence of metabolic syndrom...
Visceral adipose tissue (VAT) is a key pathogenic fat depot in the metabolic syndrome (MetS), but li...
Visceral adipose tissue (VAT) is a key pathogenic fat depot in the metabolic syndrome (MetS), but li...
Visceral adipose tissue (VAT) is a key pathogenic fat depot in the metabolic syndrome (MetS), but li...
A large body of experimental and epidemiological evidence has established an association between vis...
Metabolic syndrome (MetS) represents a combination of cardio-metabolic risk factors, including visce...
The aim of this review is to look critically at the widely accepted notion that visceral fat accumul...
The aim of this review is to look critically at the widely accepted notion that visceral fat accumul...
Although it has been demonstrated that visceral adipose tissue content and serum levels of adiponect...
Metabolic syndrome (MetS) represents a combination of cardiometabolic risk factors, including viscer...
Although it has been demonstrated that visceral adipose tissue content and serum levels of adiponect...
Metabolic syndrome (MetS) represents a combination of cardiometabolic risk factors, including viscer...
There is currently substantial confusion between the conceptual definition of the metabolic syndrome...
Metabolic syndrome has been the topic of countless publications. It still remains a subject of debat...
In this review, we have analyzed the role of visceral obesity in the occurrence of metabolic syndrom...
In this review, we have analyzed the role of visceral obesity in the occurrence of metabolic syndrom...
Visceral adipose tissue (VAT) is a key pathogenic fat depot in the metabolic syndrome (MetS), but li...
Visceral adipose tissue (VAT) is a key pathogenic fat depot in the metabolic syndrome (MetS), but li...
Visceral adipose tissue (VAT) is a key pathogenic fat depot in the metabolic syndrome (MetS), but li...
A large body of experimental and epidemiological evidence has established an association between vis...
Metabolic syndrome (MetS) represents a combination of cardio-metabolic risk factors, including visce...
The aim of this review is to look critically at the widely accepted notion that visceral fat accumul...
The aim of this review is to look critically at the widely accepted notion that visceral fat accumul...
Although it has been demonstrated that visceral adipose tissue content and serum levels of adiponect...
Metabolic syndrome (MetS) represents a combination of cardiometabolic risk factors, including viscer...
Although it has been demonstrated that visceral adipose tissue content and serum levels of adiponect...
Metabolic syndrome (MetS) represents a combination of cardiometabolic risk factors, including viscer...
There is currently substantial confusion between the conceptual definition of the metabolic syndrome...
Metabolic syndrome has been the topic of countless publications. It still remains a subject of debat...